Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilnidipine/Valsartan in Hypertension
NCT02145104Phase 3Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Jun 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilnidipine in essential hypertension, sponsored by Ildong Pharmaceutical Co Ltd. Started Jun 2014; status: completed.
02
Drugs
cilnidipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02145104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145104.